Jim Jorgenson, CEO, Visante

As 2020 comes to a close, we recognize it has been a year like no other! Dominated by challenges and uncertainty with the pandemic and the economy, and the political landscape overshadowing everything.

As always, and particularly in the face of rising challenges, we would like to thank our many clients for trusting us to support their organizations and to help them weather the storm as we head into what will hopefully be a better 2021.

As we look ahead, as in years past, we are pleased to offer our insight and perspective on what we think will be the Top 10 items for pharmacy to consider in 2021. There is no doubt many of the challenges we face now will continue into 2021, but with big challenges also come big opportunities and we are very heartened and optimistic about the capability of pharmacy to step up and be a solution for many of these challenges. In 2021, we see expanded opportunities for pharmacy to take a greater leadership role and make larger organizational contributions to quality, safety and finances.

As someone much wiser than I once said, “It’s important to remember not to get overwhelmed by these challenges but to remember to focus on what we can control which is: what we think, what we say and what we do.” At Visante we are thinking and acting to advance the business of pharmacy across all aspects of the healthcare continuum and are looking forward to helping even more organizations in the new year.

Jim’s Top 10

Here is a quick synopsis of each topic. We invite you to click on the topic to read more from our team.

(1) Pharmacy Organization Structure
Pharmacy is moving to the top of a lot of lists as a potential resource that has typically been undervalued and underutilized. We see organizational structures advancing to increasingly support health systems in their efforts to become high-performing pharmacy enterprises and provide our thoughts on this trend and the optimal model.

(2) 340B Program
We consider the impact of pharma manufacturer activity and how best to position programs for long-term success in this update.

(3) Vertical Integration & Marketplace Restrictions
Merger & acquisition activity continues, and marketplace relationships and allegiances are shifting and ever-changing. Learn about the impact of these developments for hospital pharmacy.

(4) Drug Prices and the Supply Chain
We outlined six important trends impacting the pharmaceutical supply chain and drug pricing in this article.

(5) Infusion Services
A significant growth area in 2021, factors for success include collaboration with all stakeholders, a holistic approach and definitely being proactive.

(6) Drug Shortages
COVID19 is exacerbating drug shortage issues for U.S. health systems and hospitals. Innovation is needed but in the meantime risk mitigation strategies and programs are advised.

(7) The Pandemic
The pharmacy community continues to rise to monumental challenges. 2021 will bring a new Administration and approach which will further strengthen the U.S. response.

(8) The Economy
Health system pharmacy will be key to financial recovery and performance. We’ve outlined a number of key initiatives to consider for both the short and long term.

(9) The Election
We outline key factors to consider in healthcare policy, and review some areas of immediate impact with the new Administration.

(10) Social Justice
Healthcare—and pharmacy specifically—has an obligation and opportunity to support social justice. We’re excited to be part of the future.

Click on a topic to read about it, or click here to read the article in full.